Source: Healio Coverage
September 30, 2020
1 min read

Top in endocrinology: Once-weekly insulin, weight loss in type 2 diabetes

Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The efficacy of an investigational, once-weekly insulin therapy was similar to daily insulin glargine in patients with type 2 diabetes, according to data from a phase 2 trial. It was the top story in endocrinology last week.

Another top story was about research that showed weight loss can help restore pancreas function among people experiencing type 2 diabetes remission.

Insulin pens 2019 Adobe
Source: Adobe Stock

Read these and more top stories in endocrinology below:

Once-weekly insulin efficacy similar to daily therapy in type 2 diabetes

Adults with type 2 diabetes assigned to an investigational, once-weekly insulin therapy experienced a decrease in HbA1c similar to that seen with daily insulin glargine, according to findings from a phase 2 randomized controlled trial. Read more.

Weight loss may restore pancreas function in type 2 diabetes

Weight loss can help the pancreas return to its normal size and shape for people experiencing type 2 diabetes remission, according to a presenter at the European Association for the Study of Diabetes virtual meeting. Read more.

Later menarche associated with better cardiovascular health

Women who had menarche at a later age are more likely to have better cardiovascular health, according to a study published in Menopause. Read more.

‘We have more to learn’: Data inconclusive on COVID-19 driving form of type 1 diabetes

Reports of patients developing new-onset type 1 diabetes in the setting of COVID-19 infection have researchers questioning whether the virus is entering and subsequently destroying beta cells in pancreatic islets, according to a speaker. Read more.

Greater exercise capacity could mean longer life for adults with type 2 diabetes

Among people with type 2 diabetes, those with increased exercise capacity had a significantly decreased risk for all-cause mortality, according to data presented at the virtual European Association for the Study of Diabetes annual meeting. Read more.